Experimental Drug Offers 'Functional Cure' For Chronic Hepatitis B
According to data published in the New England Journal of Medicine and reported by the Associated Press and CNN, the drug, bepirovirsen, eliminated detectable traces of the liver virus in nearly 20 percent of trial participants